Compare Elder Pharma with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DISHMAN PHARMA ELDER PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x -0.2 25.1 - View Chart
P/BV x 0.1 3.3 3.0% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ELDER PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DISHMAN PHARMA
Mar-16
ELDER PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs380374 101.5%   
Low Rs188129 145.8%   
Sales per share (Unadj.) Rs491.2197.8 248.3%  
Earnings per share (Unadj.) Rs-3.221.2 -15.0%  
Cash flow per share (Unadj.) Rs14.434.7 41.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.5179.9 209.3%  
Shares outstanding (eoy) m20.5480.69 25.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.61.3 45.4%   
Avg P/E ratio x-89.311.9 -752.2%  
P/CF ratio (eoy) x19.77.2 272.0%  
Price / Book Value ratio x0.81.4 53.9%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m5,83320,306 28.7%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m2,1795,355 40.7%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m10,08915,961 63.2%  
Other income Rs m257265 96.7%   
Total revenues Rs m10,34616,226 63.8%   
Gross profit Rs m-7924,103 -19.3%  
Depreciation Rs m3611,091 33.1%   
Interest Rs m2,756944 291.9%   
Profit before tax Rs m-3,6532,334 -156.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125624 20.1%   
Profit after tax Rs m-651,711 -3.8%  
Gross profit margin %-7.825.7 -30.5%  
Effective tax rate %-3.426.7 -12.8%   
Net profit margin %-0.610.7 -6.0%  
BALANCE SHEET DATA
Current assets Rs m9,24011,018 83.9%   
Current liabilities Rs m9,9989,517 105.1%   
Net working cap to sales %-7.59.4 -79.9%  
Current ratio x0.91.2 79.8%  
Inventory Days Days46110 41.9%  
Debtors Days Days6035 172.1%  
Net fixed assets Rs m10,12416,304 62.1%   
Share capital Rs m206161 127.4%   
"Free" reserves Rs m5,58212,907 43.3%   
Net worth Rs m7,73414,516 53.3%   
Long term debt Rs m4,8894,189 116.7%   
Total assets Rs m22,88229,805 76.8%  
Interest coverage x-0.33.5 -9.4%   
Debt to equity ratio x0.60.3 219.0%  
Sales to assets ratio x0.40.5 82.3%   
Return on assets %11.88.9 132.0%  
Return on equity %-0.811.8 -7.2%  
Return on capital %22.317.5 127.3%  
Exports to sales %3.024.8 12.3%   
Imports to sales %0.43.7 11.4%   
Exports (fob) Rs m3073,956 7.7%   
Imports (cif) Rs m43596 7.2%   
Fx inflow Rs m3074,952 6.2%   
Fx outflow Rs m125697 18.0%   
Net fx Rs m1814,255 4.3%   
CASH FLOW
From Operations Rs m11,7542,786 421.8%  
From Investments Rs m-561-1,529 36.7%  
From Financial Activity Rs m-6,762-941 718.5%  
Net Cashflow Rs m4,432316 1,400.7%  

Share Holding

Indian Promoters % 39.6 61.4 64.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 16.8 12.7 132.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 22.1 163.3%  
Shareholders   16,479 46,261 35.6%  
Pledged promoter(s) holding % 77.6 35.8 216.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   NATCO PHARMA  PANACEA BIOTECH  FDC LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare ELDER PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 429 Points Higher; Auto and IT Stocks Rally(Closing)

Indian share markets extended gains for the second consecutive day and ended on a strong note, tracking gains in Asian peers and Wall Street.

Related Views on News

Most Popular

This is How You Should Trade Intraday(Fast Profits Daily)

Jun 19, 2020

In this video, I'll show you how to trade the market intraday like a professional trader.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - PIRAMAL ENTERPRISES COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS